COVID-19: Understanding a New Disease Through Global Efforts
DOI:
https://doi.org/10.17986/blm.2020.v25i.1409Keywords:
COVID-19, Pandemic, Pathogenesis, AutopsyAbstract
COVID-19, the disease caused by the novel coronavirus SARS-CoV-2 which was first reported in Wuhan, China in December 2019, is seen to have left its mark in the history with a global pandemic. As a novel member of the coronavirus family, SARS-CoV-2 represents a new kind of sickness in regard to viral pathogenesis and tissue changes. To comprehend the pathogenicity of the virus totally, one has to follow the pathways which a virus travels and inflicts damage through. What starts out as a simple fever and coughing carries the potential to lead to shock, multi – organ failure and death even in the most unsuspected of cases. When faced with a challenge as contagious, deadly and widespread as this, one should put all the efforts that they have in order to overcome this obstacle. In the case of COVID-19 this cumulative effort has shaped itself into a globalized form. In an attempt to see the wider picture as to the whole pathogenesis of COVID-19, the medical and scientific society should recall the importance of a fundamental discipline, namely, autopsy. Even though, conducted in small numbers at the time, autopsies of COVID-19 cases have provided the literature with many important information. The role of autopsy in understanding disease, the immune system and pathogenesis is one that should not be disregarded and conversely, should be further developed and praised. The same ideology would apply to COVID-19 and any further pandemics to come.
Downloads
References
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virology. 2020;92(4):418-23. doi: 10.1002/jmv.25681. DOI: https://doi.org/10.1002/jmv.25681
Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerging Microbes Infections. 2020;9(1):558-70. doi: 10.1080/22221751.2020.1736644. DOI: https://doi.org/10.1080/22221751.2020.1736644
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019;17(3):181-92. doi: 10.1038/s41579-018-0118-9. DOI: https://doi.org/10.1038/s41579-018-0118-9
Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020.
Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacology & therapeutics. 2010;128(1):119-28. doi: 10.1016/j.pharmthera.2010.06.003. DOI: https://doi.org/10.1016/j.pharmthera.2010.06.003
Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv. 2020:2020.04.19.049254. doi: https://doi.org/10.1101/2020.04.19.049254 DOI: https://doi.org/10.1101/2020.04.19.049254
Chu H, Chan JF-W, Yuen TT-T, Shuai H, Yuan S, Wang Y, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020. DOI:10.1016/S2666-5247(20)30004-5 DOI: https://doi.org/10.1016/S2666-5247(20)30004-5
Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020. DOI: 10.1016/j.cell.2020.03.045 DOI: https://doi.org/10.1016/j.cell.2020.03.045
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-80.e8. DOI: 10.1016/j.cell.2020.02.052 DOI: https://doi.org/10.1016/j.cell.2020.02.052
Li F. Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virology. 2015;89(4):1954-64. doi: 10.1128/JVI.02615-14. DOI: https://doi.org/10.1128/JVI.02615-14
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020. doi: 10.1001/jama.2020.6775. DOI: https://doi.org/10.1001/jama.2020.6775
Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annual Review Pathol. 2011;6:147-63. DOI: 10.1146/annurev-pathol-011110-130158 DOI: https://doi.org/10.1146/annurev-pathol-011110-130158
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2020;15(5):700-4. doi: 10.1016/j.jtho.2020.02.010. DOI: https://doi.org/10.1016/j.jtho.2020.02.010
Carsana L, Sonzogni A, Nasr A, Rossi R, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy. medRxiv. 2020:2020.04.19.20054262. doi: https://doi.org/10.1101/2020.04.19.20054262 DOI: https://doi.org/10.1101/2020.04.19.20054262
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. doi: 10.1016/S0140-6736(20)30937-5. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5
Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clinical Pathol. 2020;153(6):725-33. doi: 10.1093/ajcp/aqaa062. DOI: https://doi.org/10.1093/ajcp/aqaa062
Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020:1-4. DOI: 10.1007/s00134-020-06059-6 DOI: https://doi.org/10.1007/s00134-020-06059-6
Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nature rRviews Immunology. 2020:1-8. doi: 10.1038/s41577-020-0331-4. DOI: https://doi.org/10.1038/s41577-020-0331-4
Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunology (Baltimore, Md : 1950). 2015;194(3):855-60. doi: 10.4049/jimmunol.1402513. DOI: https://doi.org/10.4049/jimmunol.1402513
Huang X, Xiu H, Zhang S, Zhang G. The Role of Macrophages in the Pathogenesis of ALI/ARDS. Mediators Inflammation. 2018;2018:1264913. doi: 10.1155/2018/1264913. DOI: https://doi.org/10.1155/2018/1264913
Blondonnet R, Constantin JM, Sapin V, Jabaudon M. A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome. Disease markers. 2016;2016:3501373. doi: 10.1155/2016/3501373. DOI: https://doi.org/10.1155/2016/3501373
Frantzeskaki F, Armaganidis A, Orfanos SE. Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration; Int Review Thoracic Diseases. 2017;93(3):212-25. doi: 10.1159/000453002. DOI: https://doi.org/10.1159/000453002
Pfeiler S, Stark K, Massberg S, Engelmann B. Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica. 2017;102(2):206-13. doi: 10.3324/haematol.2016.142471. DOI: https://doi.org/10.3324/haematol.2016.142471
Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology. 2006;344(1):119-30. doi: 10.1016/j.virol.2005.09.024. DOI: https://doi.org/10.1016/j.virol.2005.09.024
Schoggins JW. Interferon-stimulated genes: roles in viral pathogenesis. Current opinion in virology. 2014;6:40-6. doi: 10.1016/j.coviro.2014.03.006. DOI: https://doi.org/10.1016/j.coviro.2014.03.006
Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovascular Electrophysiology. 2020;31(5):1003-8. DOI: 10.1111/jce.14479 DOI: https://doi.org/10.1111/jce.14479
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. doi: 10.1001/jama.2020.2648. DOI: https://doi.org/10.1001/jama.2020.2648
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585. DOI: https://doi.org/10.1001/jama.2020.1585
Lau ST, Yu WC, Mok NS, Tsui PT, Tong WL, Cheng SW. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS). Int J Cardiology. 2005;100(1):167-9. doi: 10.1016/j.ijcard.2004.06.022. DOI: https://doi.org/10.1016/j.ijcard.2004.06.022
Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2014;29:301-6. doi: 10.1016/j.ijid.2014.09.003. DOI: https://doi.org/10.1016/j.ijid.2014.09.003
Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)--worldwide, 2012-2013. MMWR Morbidity and mortality weekly report. 2013;62(23):480-3. DOI: https://doi.org/10.1016/j.annemergmed.2013.06.002
Sellers SA, Hagan RS, Hayden FG, Fischer WA, 2nd. The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza and other respiratory viruses. 2017;11(5):372-93. doi: 10.1111/irv.12470. DOI: https://doi.org/10.1111/irv.12470
Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgraduate Med J. 2006;82(964):140-4. doi: 10.1136/pgmj.2005.037515. DOI: https://doi.org/10.1136/pgmj.2005.037515
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Med. 2020;8(5):475-81. doi: 10.1016/S2213-2600(20)30079-5. DOI: https://doi.org/10.1016/S2213-2600(20)30079-5
Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. doi: 10.1007/s00059-020-04909-z. DOI: https://doi.org/10.1007/s00059-020-04909-z
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:91-5. doi: 10.1016/j.ijid.2020.03.017. DOI: https://doi.org/10.1016/j.ijid.2020.03.017
Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections. medRxiv. 2020:2020.04.17.20058545. doi: https://doi.org/10.1101/2020.04.17.20058545 DOI: https://doi.org/10.1101/2020.04.17.20058545
Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. J Clinical Pathol. 2020;73(5):239-42. doi: 10.1136/jclinpath-2020-206522. DOI: https://doi.org/10.1136/jclinpath-2020-206522
Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020:1-5. doi: 10.1007/s15010-020-01424-5. DOI: https://doi.org/10.1007/s15010-020-01424-5
Stanciu AE. Cytokines in heart failure. Advances Clinical Chemistry. 2019;93:63-113. doi: 10.1016/bs.acc.2019.07.002. DOI: https://doi.org/10.1016/bs.acc.2019.07.002
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091. doi: 10.1136/bmj.m1091. DOI: https://doi.org/10.1136/bmj.m1091
Groß S, Jahn C, Cushman S, Bär C, Thum T. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J Molecular Cellular Cardiol. 2020. doi: 10.1016/j.yjmcc.2020.04.031. DOI: https://doi.org/10.1016/j.yjmcc.2020.04.031
Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020. doi: 10.1001/jama.2020.3633. DOI: https://doi.org/10.1001/jama.2020.3633
Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36(1):78-80. doi: 10.5144/0256-4947.2016.78. DOI: https://doi.org/10.5144/0256-4947.2016.78
Pan SF, Zhang HY, Li CS, Wang C. [Cardiac arrest in severe acute respiratory syndrome: analysis of 15 cases]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese J Tuberculosis Respiratory Diseases. 2003;26(10):602-5.
Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA cardiology. 2016;1(3):274-81. doi: 10.1001/jamacardio.2016.0433. DOI: https://doi.org/10.1001/jamacardio.2016.0433
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am College Cardiol. 2020;75(18):2352-71. doi: 10.1016/j.jacc.2020.03.031. DOI: https://doi.org/10.1016/j.jacc.2020.03.031
Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am College Cardiol. 2020;75(18):2372-5. doi: 10.1016/j.jacc.2020.03.021. DOI: https://doi.org/10.1016/j.jacc.2020.03.021
Bansal M. Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome. 2020;14(3):247-50. doi: 10.1016/j.dsx.2020.03.013. DOI: https://doi.org/10.1016/j.dsx.2020.03.013
Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. J Cardiac Failure. 2020. doi: 10.1016/j.cardfail.2020.04.009. DOI: https://doi.org/10.1016/j.cardfail.2020.04.009
Mirzaei H, Ferns GA, Avan A, Mobarhan MG. Cytokines and MicroRNA in Coronary Artery Disease. Advances in clinical chemistry. 2017;82:47-70. doi: 10.1016/bs.acc.2017.06.004. DOI: https://doi.org/10.1016/bs.acc.2017.06.004
Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146(6):980-91. doi: 10.1016/j.cell.2011.08.015. DOI: https://doi.org/10.1016/j.cell.2011.08.015
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020;17(5):259-60. doi: 10.1038/s41569-020-0360-5. DOI: https://doi.org/10.1038/s41569-020-0360-5
Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, et al. Viral infections associated with Kawasaki disease. Journal of the Formosan Medical Association = Taiwan yi zhi. 2014;113(3):148-54. doi: 10.1016/j.jfma.2013.12.008. DOI: https://doi.org/10.1016/j.jfma.2013.12.008
Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virology. 2014;86(12):2146-53. doi: 10.1002/jmv.23950. DOI: https://doi.org/10.1002/jmv.23950
Giray T, Biçer S, Küçük Ö, Çöl D, Yalvaç Z, Gürol Y, et al. Four cases with Kawasaki disease and viral infection: aetiology or association. Le infezioni in medicina. 2016;24(4):340-4.
Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020:1-3. DOI: 10.1007/s00134-020-06026-1 DOI: https://doi.org/10.1007/s00134-020-06026-1
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? European Heart J. 2020. doi: 10.1093/eurheartj/ehaa254 DOI: https://doi.org/10.1093/eurheartj/ehaa254
Cellina M, Oliva G. Acute pulmonary embolism in a patient with COVID-19 pneumonia. Diagnostic Interventional Imaging. 2020;101(5):325-6. doi: 10.1016/j.diii.2020.04.001. DOI: https://doi.org/10.1016/j.diii.2020.04.001
Ratliff NB, Estes ML, McMahon JT, Myles JL. Chloroquine-induced cardiomyopathy. Archives Pathol Lab Med. 1988;112(6):578.
Siqueira-Batista R, Ramos Júnior AN, Pessanha BS, Sforza-de-Almeida MP, Potsch DF. Chloroquine and cardiac arrhythmia: case report. East African Med J. 1998;75(2):117-9.
Capel RA, Herring N, Kalla M, Yavari A, Mirams GR, Douglas G, et al. Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential. Heart rhythm. 2015;12(10):2186-94. doi: 10.1016/j.hrthm.2015.05.027. DOI: https://doi.org/10.1016/j.hrthm.2015.05.027
Sapp JL, Alqarawi W, MacIntyre CJ, Tadros R, Steinberg C, Roberts JD, et al. Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Canadian J Cardiol. 2020. DOI: 10.1016/j.cjca.2020.04.003 DOI: https://doi.org/10.1016/j.cjca.2020.04.003
DeCarolis DD, Westanmo AD, Chen YC, Boese AL, Walquist MA, Rector TS. Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin. The Ann Pharmacotherapy. 2016;50(11):909-17. DOI: 10.1177/1060028016660325 DOI: https://doi.org/10.1177/1060028016660325
Page RL, 2nd, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016;134(6):e32-69. doi: 10.1161/CIR.0000000000000426. DOI: https://doi.org/10.1161/CIR.0000000000000426
Wright EJ, Brew BJ, Wesselingh SL. Pathogenesis and diagnosis of viral infections of the nervous system. Neurologic Clinics. 2008;26(3):617-33, vii. doi: 10.1016/j.ncl.2008.03.006. DOI: https://doi.org/10.1016/j.ncl.2008.03.006
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell host & microbe. 2020;27(3):325-8. doi: 10.1016/j.chom.2020.02.001. DOI: https://doi.org/10.1016/j.chom.2020.02.001
Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacological Sci. 2004;25(6):291-4. doi: 10.1016/j.tips.2004.04.001. DOI: https://doi.org/10.1016/j.tips.2004.04.001
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA neurology. 2020. doi: 10.1001/jamaneurol.2020.1127. DOI: https://doi.org/10.1001/jamaneurol.2020.1127
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7. DOI: https://doi.org/10.1016/S0140-6736(20)30211-7
Li Y, Li H, Fan R, Wen B, Zhang J, Cao X, et al. Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children. Intervirology. 2016;59(3):163-9. doi: 10.1159/000453066. DOI: https://doi.org/10.1159/000453066
Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Experimental Med. 2005;202(3):415-24. doi: 10.1084/jem.20050828. DOI: https://doi.org/10.1084/jem.20050828
State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS currents. 2013;5. DOI: 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8. DOI: https://doi.org/10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity. 2020. doi: 10.1016/j.bbi.2020.03.031. DOI: https://doi.org/10.1016/j.bbi.2020.03.031
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS chemical neuroscience. 2020;11(7):995-8. doi: 10.1021/acschemneuro.0c00122. DOI: https://doi.org/10.1021/acschemneuro.0c00122
Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: Underestimated damage to nervous system. Travel medicine and infectious disease. 2020:101642. doi: 10.1016/j.tmaid.2020.101642. DOI: https://doi.org/10.1016/j.tmaid.2020.101642
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:55-8. doi: 10.1016/j.ijid.2020.03.062. DOI: https://doi.org/10.1016/j.ijid.2020.03.062
Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain, behavior, and immunity. 2020. doi: 10.1016/j.bbi.2020.04.024. DOI: https://doi.org/10.1016/j.bbi.2020.04.024
Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43. J Virology. 2018;92(17). doi: 10.1128/JVI.00404-18. DOI: https://doi.org/10.1128/JVI.00404-18
Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurological Sci. 2020;412:116824. doi: 10.1016/j.jns.2020.116824. DOI: https://doi.org/10.1016/j.jns.2020.116824
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virology. 2020. doi: 10.1002/jmv.25728. doi: 10.1021/acschemneuro.0c00201. DOI: https://doi.org/10.1002/jmv.25728
Das G, Mukherjee N, Ghosh S. Neurological Insights of COVID-19 Pandemic. ACS chemical neuroscience. 2020;11(9):1206-9. doi: 10.1021/acschemneuro.0c00201. DOI: https://doi.org/10.1021/acschemneuro.0c00201
Esposito G, Pesce M, Seguella L, Sanseverino W, Lu J, Sarnelli G. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain, behavior, and immunity. 2020. doi: 10.1016/j.bbi.2020.04.060. DOI: https://doi.org/10.1016/j.bbi.2020.04.060
Abdennour L, Zeghal C, Dème M, Puybasset L. [Interaction brain-lungs]. Annales francaises d'anesthesie et de reanimation. 2012;31(6):e101-7. doi: 10.1016/j.annfar.2012.04.013. DOI: https://doi.org/10.1016/j.annfar.2012.04.013
Li Y, Fu L, Gonzales DM, Lavi E. Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virology. 2004;78(7):3398-406. doi: 10.1128/jvi.78.7.3398-3406.2004. DOI: https://doi.org/10.1128/JVI.78.7.3398-3406.2004
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology. 2020:201187. doi: 10.1148/radiol.2020201187. DOI: https://doi.org/10.1148/radiol.2020201187
Miller AJ, Arnold AC. The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 2019;29(2):231-43. doi: 10.1007/s10286-018-0572-5. DOI: https://doi.org/10.1007/s10286-018-0572-5
Wüthrich C, Batson S, Koralnik IJ. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathology Experimental Neurology. 2015;74(8):791-803. doi: 10.1097/NEN.0000000000000218. DOI: https://doi.org/10.1097/NEN.0000000000000218
Downloads
Published
Issue
Section
License
Copyright (c) 2020 The Bulletin of Legal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
